Press releases

Release
09.06.2017

VALBIOTIS will present the results of its Phase I/II clinical study on the active ingredient of Valedia®, TOTUM-63, during the 77th Scientific Sessions of the American Diabetes Association.

Download
Release
02.06.2017

VALBIOTIS Initial Public Offering records huge success

Download
Release
24.04.2017

Sébastien PELTIER, CEO of VALBIOTIS, presents his vision of diabetes-free world at l’Echappée Volée

Download
Release
12.04.2017

Two partnership agreements to assess the effects of TOTUM-63, the active ingredient Valedia®, on intestinal microbiota

Download
Release
30.03.2017

VALBIOTIS at the 77th scientific sessions of the American Diabetes Association

Download